abstract |
Endothelin receptor antagonist nitroderivatives of general formula (I) having an improved pharmacological activity compared with their parent compounds. They can be employed for treating or preventing endothelial-related disorders, renal, pulmonary, cardiac and vascular diseases, and inflammatory processes. |